You Get What You Pay For | GenomeWeb

As we approach the 10th anniversary of the sequencing of the first human genome, the price of sequencing has gone down from a few million dollars to a few thousand. Researchers are talking about the advent of $1,000 genome as sequencing technology becomes faster and more efficient. But does cheaper mean better? Not necessarily, says The New Scientist's Michael Le Page.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.